<DOC>
	<DOCNO>NCT00169039</DOCNO>
	<brief_summary>This study examine physical response clozapine chlorpromazine people schizophrenia improve treatment .</brief_summary>
	<brief_title>Clozapine Versus Chlorpromazine Treatment-Unresponsive Schizophrenia</brief_title>
	<detailed_description>This longitudinal double-blind 12-week study clinical biochemical response clozapine chlorpromazine group treatment-refractory schizophrenic patient . The study 4 phase : ( 1 ) A recruitment period ; ( 2 ) period discontinuation psychotropic medication ; ( 3 ) drug-washout period ; ( 4 ) 12-week double-blind trial clozapine chlorpromazine .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Chlorpromazine</mesh_term>
	<criteria>1960 year age Diagnosis schizophrenia BPRS score &gt; 50 Clinical Global Impressions rating &gt; 4 One following : BPRS item rat great equal 4 , conceptual disorganization , suspiciousness , hallucination , unusual thought content . At least 2 sixweek trial different neuroleptic give dosage equivalent least 600 mg per day chlorpromazine OR least 1 eightweek trial neuroleptic give dosage equivalent least 800 mg per day chlorpromazine . The patient ( patient 's authorized legal representative ) must understand nature study sign inform consent . History substance dependence within past 2 month Major medical problem preclude use clozapine Pregnancy lactation A serious suicide/homicide risk</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Clozapine</keyword>
	<keyword>Chlorpromazine</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Biochemistry</keyword>
</DOC>